|
1
|
Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.
|
J Am Coll Cardiol
|
2005
|
1.99
|
|
2
|
Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation.
|
Catheter Cardiovasc Interv
|
2003
|
1.95
|
|
3
|
A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
|
Blood
|
2003
|
1.55
|
|
4
|
A stimulatory role for cGMP-dependent protein kinase in platelet activation.
|
Cell
|
2003
|
1.54
|
|
5
|
ADP-induced platelet aggregation frequently fails to detect impaired clopidogrel-responsiveness in patients with coronary artery disease compared to a P2Y12-specific assay.
|
Thromb Haemost
|
2008
|
1.40
|
|
6
|
Fibronectin mediates Opc-dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells.
|
Mol Microbiol
|
2002
|
1.33
|
|
7
|
Vasodilator-stimulated phosphoprotein regulates proliferation and growth inhibition by nitric oxide in vascular smooth muscle cells.
|
Arterioscler Thromb Vasc Biol
|
2004
|
1.31
|
|
8
|
Rapid regulation of platelet activation in vivo by nitric oxide.
|
Circulation
|
2004
|
1.17
|
|
9
|
Enhanced in vivo platelet adhesion in vasodilator-stimulated phosphoprotein (VASP)-deficient mice.
|
Blood
|
2003
|
1.13
|
|
10
|
Interaction of Neisseria meningitidis with human brain microvascular endothelial cells: role of MAP- and tyrosine kinases in invasion and inflammatory cytokine release.
|
Cell Microbiol
|
2004
|
1.08
|
|
11
|
Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion.
|
Blood
|
2003
|
1.01
|
|
12
|
Variable extent of clopidogrel responsiveness in patients after coronary stenting.
|
Thromb Haemost
|
2004
|
0.99
|
|
13
|
Vasodilator-stimulated phosphoprotein activation of serum-response element-dependent transcription occurs downstream of RhoA and is inhibited by cGMP-dependent protein kinase phosphorylation.
|
J Biol Chem
|
2003
|
0.99
|
|
14
|
Gene expression pattern in human brain endothelial cells in response to Neisseria meningitidis.
|
Infect Immun
|
2006
|
0.96
|
|
15
|
Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic rats.
|
Arterioscler Thromb Vasc Biol
|
2006
|
0.93
|
|
16
|
Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo.
|
Arterioscler Thromb Vasc Biol
|
2004
|
0.93
|
|
17
|
Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability.
|
Arterioscler Thromb Vasc Biol
|
2005
|
0.93
|
|
18
|
Cyclic nucleotide-regulated proliferation and differentiation vary in human hematopoietic progenitor cells derived from healthy persons, tumor patients, and chronic myelocytic leukemia patients.
|
Stem Cells Dev
|
2008
|
0.91
|
|
19
|
The CX3C chemokine fractalkine induces vascular dysfunction by generation of superoxide anions.
|
Arterioscler Thromb Vasc Biol
|
2006
|
0.84
|
|
20
|
Increased noise sensitivity and altered inner ear MENA distribution in VASP-/- mice.
|
Cell Tissue Res
|
2004
|
0.83
|
|
21
|
Reduced basal nitric oxide bioavailability and platelet activation in young spontaneously hypertensive rats.
|
Biochem Pharmacol
|
2004
|
0.83
|
|
22
|
Infection of human coronary artery endothelial cells by group B streptococcus contributes to dysregulation of apoptosis, hemostasis, and innate immune responses.
|
Mediators Inflamm
|
2011
|
0.82
|
|
23
|
Group B streptococcus isolates from septic patients and healthy carriers differentially activate platelet signaling cascades.
|
Thromb Haemost
|
2006
|
0.82
|
|
24
|
Expanding the spectrum of PTH1R mutations in patients with primary failure of tooth eruption.
|
Clin Oral Investig
|
2013
|
0.82
|
|
25
|
Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot study.
|
J Clin Psychopharmacol
|
2003
|
0.82
|
|
26
|
Phosphatidylserine surface expression and integrin alpha IIb beta 3 activity on thrombin/convulxin stimulated platelets/particles of different sizes.
|
Br J Haematol
|
2008
|
0.81
|
|
27
|
Inhibition of platelet activation in congestive heart failure by aldosterone receptor antagonism and ACE inhibition.
|
Thromb Haemost
|
2003
|
0.80
|
|
28
|
Increased platelet activation in young Zucker rats with impaired glucose tolerance is improved by acarbose.
|
Thromb Haemost
|
2004
|
0.79
|
|
29
|
Enhanced platelet activation by prolactin in patients with ischemic stroke.
|
Thromb Haemost
|
2006
|
0.78
|
|
30
|
Platelet activation in heart failure.
|
Clin Lab
|
2004
|
0.78
|
|
31
|
Hearing development and spiral ganglion neurite growth in VASP deficient mice.
|
Brain Res
|
2007
|
0.78
|
|
32
|
Delayed formation of actin filaments in the outer pillar head plate of VASP-/- mice.
|
Cells Tissues Organs
|
2006
|
0.78
|
|
33
|
Inhibition of platelet activation in rats with severe congestive heart failure by a novel endothelial nitric oxide synthase transcription enhancer.
|
Eur J Heart Fail
|
2009
|
0.77
|
|
34
|
Severe neutropenia under clopidogrel treatment three weeks after coronary stenting.
|
Thromb Haemost
|
2007
|
0.77
|
|
35
|
Neisseria meningitidis induces platelet inhibition and increases vascular endothelial permeability via nitric oxide regulated pathways.
|
Thromb Haemost
|
2011
|
0.76
|
|
36
|
Expression of VASP and zyxin in cochlear pillar cells: indication for actin-based dynamics?
|
Cell Tissue Res
|
2003
|
0.75
|
|
37
|
[Clopidogrel--clinical use and potential therapeutic problems].
|
Herz
|
2008
|
0.75
|
|
38
|
Late thrombosis of a drug-eluting stent during combined anti-platelet therapy in a clopidogrel nonresponsive diabetic patient: shall we routinely test platelet function?
|
Thromb Haemost
|
2007
|
0.75
|